BBH

VanEck Vectors Biotech ETF
*Unless otherwise stated, data provided by FactSet.

BBH Fund Description

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

BBH Factset Analytics Insight

While the global biotech industry is heavily concentrated in the US, BBH is even more concentrated in a small portfolio of just 25 US-listed companies weighted by capitalization. It also has a flexible definition of biotech, with many of the firms it holds perhaps better classified as pharmaceuticals and medical equipment rather than pure biotech. Despite the fund's conversion to a 1940 Act open-ended structure, diversification requirements have scarcely made BBH a less top-heavy, concentrated fund, with much of its portfolio comprised of a handful of companies. Despite not looking much like the global market, it's a popular fund with investors. Its daily trading volume is high, and its underlying assets are highly liquid. BBH's expense ratio is reasonable for the segment, though perhaps high for a fund that ultimately holds just 25 US-listed firms and ADRs, but tracking is undeniably close.

BBH MSCI ESG Analytics Insight

VanEck Vectors Biotech ETF has an MSCI ESG Fund Rating of BB based on a score of 3.45 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. VanEck Vectors Biotech ETF ranks in the 13th percentile within its peer group and in the 17th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

BBH MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

BBH Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 11/15/19] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BBH 10.50% 8.56% 21.02% 13.37% 6.08% 3.92% --
BBH (NAV) 10.49% 8.67% 20.36% 12.89% 6.11% 3.93% --
MVIS US Listed Biotech 25 Index -- -- -- -- -- -- --
Thomson Reuters Global Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BBH Summary Data

VanEck
11/23/99
Open-Ended Fund
0.35%
$348.78M
$1.91M
0.08%

BBH Portfolio Data

$40.99B
53.94
3.94
0.41%
12/23/19
25

BBH Index Data

Market Cap
Market Cap
Thomson Reuters Global Biotechnology & Medical Research

BBH Portfolio Management

0.35%
-0.41%
-0.33%
-0.48%

BBH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

BBH Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

BBH Factset Analytics Block Liquidity

As of 11/18/19
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBH. BBH is rated a 5 out of 5.

BBH Tradability

15,536
$1.91M
12,972
$1.50M
0.08%
$0.10
-0.03%
0.47% / -0.55%
None
100.00%
50,000
0.26
0.00%
0.23%
178
$134.00
5

BBH Sector/Industry Breakdown


BBH
Segment Benchmark
55.39%
100.00%
39.23%
--
5.38%
--

BBH Top 10 Holdings[View All]

Amgen Inc. 10.81%
59.43%

BBH Countries


BBH
Segment Benchmark
94.65%
76.12%
2.69%
1.84%
2.66%
0.02%
--
0.05%
--
6.69%
--
0.51%
--
1.03%
--
0.50%
--
0.03%
--
0.85%

BBH Regions


BBH
Segment Benchmark
94.65%
76.22%
2.69%
9.10%
2.66%
14.64%
--
0.05%

BBH Economic Development


BBH
Segment Benchmark
100.00%
99.44%
--
0.56%

BBH Performance Statistics

0.91
0.98
0.98
1.08
0.39%
Thomson Reuters Global Biotechnology & Medical Research

BBH MSCI ESG Ratings

BB
3.45 / 10
17.30
12.93
--
42.58%
20.37

BBH Benchmark Comparison Holdings

25
234
16
38.35%

BBH Benchmark Comparison Summary


BBH
Segment Benchmark
25
234
$40.99B
$23.78B
53.94
-132.03
3.94
4.47
0.73%
0.72%
High
High

BBH Benchmark Comparison Market Cap Size


BBH
Segment Benchmark
69.77%
48.72%
30.23%
28.66%
0.00%
17.79%
0.00%
4.84%